TrialAIDS research and therapy2016

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.

Nathalie de Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.